Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: The objective of this trial is to assess whether early antiviral therapy in outpatients with COVID-19 with either favipiravir plus lopinavir/ritonavir, lopinavir/ritonavir alone, or favipiravir alone, is associated with a decrease in viral load of SARS-CoV-2 compared with placebo. TRIAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Li-An K., Freemantle, Nick, Breuer, Judy, Dehbi, Hakim-Moulay, Chowdhury, Kashfia, Jones, Gemma, Ikeji, Felicia, Ndoutoumou, Amalia, Santhirakumar, Krishneya, Longley, Nicky, Checkley, Anna M., Standing, Joseph F., Lowe, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938371/
https://www.ncbi.nlm.nih.gov/pubmed/33685502
http://dx.doi.org/10.1186/s13063-021-05139-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938371/
https://www.ncbi.nlm.nih.gov/pubmed/33685502
http://dx.doi.org/10.1186/s13063-021-05139-2

Ejemplares similares